|

BCMA/CD70-targetd CAR-T Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Chongqing Precision Biotech Co., Ltd1

Indications

  • Primary Sjogren's Syndrome1
  • Juvenile Dermatomyositis (JDM)1
  • Polyarticular Juvenile Idiopathic Arthritis1
  • Systemic Sclerosis (SSc)1
  • Arthritis1

Other1 trial

Clinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic Diseases
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.